These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
68 related items for PubMed ID: 22967044
1. Analysis of induction mechanisms of an insulin-inducible transcription factor SHARP-2 gene by (-)-epigallocatechin-3-gallate. Haneishi A, Takagi K, Asano K, Nakamura S, Yamada K. J Agric Food Chem; 2012 Oct 03; 60(39):9850-5. PubMed ID: 22967044 [Abstract] [Full Text] [Related]
2. (-)-Epigallocatechin-3-gallate stimulates both AMP-activated protein kinase and nuclear factor-kappa B signaling pathways. Asano K, Takagi K, Haneishi A, Nakamura S, Yamada K. Food Chem; 2012 Sep 15; 134(2):783-8. PubMed ID: 23107691 [Abstract] [Full Text] [Related]
3. (-)-Epigallocatechin-3-gallate enhances the expression of an insulin-inducible transcription factor gene via a phosphoinositide 3-kinase/atypical protein kinase C lambda pathway. Asano K, Takagi K, Haneishi A, Yamamoto T, Tanaka T, Noguchi T, Nakamura S, Yamada K. J Agric Food Chem; 2011 Dec 28; 59(24):13360-4. PubMed ID: 22085033 [Abstract] [Full Text] [Related]
4. Analysis of regulatory mechanisms of an insulin-inducible SHARP-2 gene by (S)-Equol. Haneishi A, Takagi K, Asano K, Yamamoto T, Tanaka T, Nakamura S, Noguchi T, Yamada K. Arch Biochem Biophys; 2012 Sep 01; 525(1):32-9. PubMed ID: 22683650 [Abstract] [Full Text] [Related]
5. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Choi KC, Jung MG, Lee YH, Yoon JC, Kwon SH, Kang HB, Kim MJ, Cha JH, Kim YJ, Jun WJ, Lee JM, Yoon HG. Cancer Res; 2009 Jan 15; 69(2):583-92. PubMed ID: 19147572 [Abstract] [Full Text] [Related]
6. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH. Mol Pharmacol; 2010 Jan 15; 77(1):17-25. PubMed ID: 19828731 [Abstract] [Full Text] [Related]
7. UV-induced NF-kappaB activation and expression of IL-6 is attenuated by (-)-epigallocatechin-3-gallate in cultured human keratinocytes in vitro. Xia J, Song X, Bi Z, Chu W, Wan Y. Int J Mol Med; 2005 Nov 15; 16(5):943-50. PubMed ID: 16211268 [Abstract] [Full Text] [Related]
8. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Lin YL, Lin JK. Mol Pharmacol; 1997 Sep 15; 52(3):465-72. PubMed ID: 9281609 [Abstract] [Full Text] [Related]
13. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB. Lee MH, Han DW, Hyon SH, Park JC. Apoptosis; 2011 Jan 22; 16(1):75-85. PubMed ID: 20963498 [Abstract] [Full Text] [Related]
14. The LIM-homeodomain transcription factor LMX1B regulates expression of NF-kappa B target genes. Rascle A, Neumann T, Raschta AS, Neumann A, Heining E, Kastner J, Witzgall R. Exp Cell Res; 2009 Jan 01; 315(1):76-96. PubMed ID: 18996370 [Abstract] [Full Text] [Related]
16. Exchange of a nuclear corepressor between NF-kappaB and CREB mediates inhibition of phosphoenolpyruvate carboxykinase transcription by NF-kappaB. Yan JH, Gao ZG, Ye JP, Weng JP. Chin Med J (Engl); 2010 Jan 20; 123(2):221-6. PubMed ID: 20137375 [Abstract] [Full Text] [Related]
17. SHARP-2/Stra13/DEC1 as a potential repressor of phosphoenolpyruvate carboxykinase gene expression. Yamada K, Ogata-Kawata H, Matsuura K, Miyamoto K. FEBS Lett; 2005 Feb 28; 579(6):1509-14. PubMed ID: 15733865 [Abstract] [Full Text] [Related]